Early NSCLC: Achieving a Fitting Response to a Heterogeneous Disease

Sandip P. Patel, MD


August 01, 2022

Sandip Patel, MD, describes the developing dynamic between disease and treatment in the context of early non–small cell lung cancer (NSCLC).

Specifically, he discusses how the variegated presentation of forms of the disorder requires a range of specialists and subspecialists working jointly in order to provide sound and effective therapy for patients.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.